| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/09/2009 | WO2009083664A1 Novel taxoid-based compositions |
| 07/09/2009 | WO2009083520A2 Liquid oral florfenicol compositions which can be diluted in drinking water |
| 07/09/2009 | WO2009083131A2 Cosmetic, pharmaceutical or dermatological compositions having a high content of water-soluble care components |
| 07/09/2009 | WO2009082817A1 Silencing of polo-like kinase expression using interfering rna |
| 07/09/2009 | WO2009056114A3 Use of polyethylene glycol powders, and compositions containing the same |
| 07/09/2009 | WO2009052942A3 Stabilization of hydrophobic protein therapeutic agents |
| 07/09/2009 | WO2009047321A3 A sublingual effervescent tablet of progesterone associated with cyclodextrin |
| 07/09/2009 | WO2009036368A3 Drug carriers |
| 07/09/2009 | WO2009009562A3 Glp-1-fc fusion protein formulation |
| 07/09/2009 | US20090177273 Anisotropic nanoporous coatings for medical implants |
| 07/09/2009 | US20090176892 Soluble Hydrophobic Core Carrier Compositions for Delivery of Therapeutic Agents, Methods of Making and Using the Same |
| 07/09/2009 | US20090176884 Pharmaceutical suspension composition |
| 07/09/2009 | US20090176874 Tnp-470 polymer conjugates and use thereof |
| 07/09/2009 | US20090176852 Temozolomide FDA Orange book listed patent; water soluble, and storage stable formulation; L-threonine as dissolution enhancer |
| 07/09/2009 | US20090176795 Enhanced delivery of antifungal agents |
| 07/09/2009 | US20090176750 Specified ratio of penetration enhancers to solvents and emulsifiers; fluocinolone |
| 07/09/2009 | US20090176720 Compositions containing piperacillin and tazobactam useful for injection |
| 07/09/2009 | US20090176700 Derivatives Of GLP-1 Analogs |
| 07/09/2009 | US20090176276 Fusion Polypeptides of Human Serum Albumin and a Therapeutically Active Polypeptide |
| 07/09/2009 | US20090175959 Controlled Release Solid Preparation |
| 07/09/2009 | US20090175932 Micelle assemblies |
| 07/09/2009 | US20090175893 Albumin-Fused Anti-Angiogenesis Peptides |
| 07/09/2009 | US20090175888 Methods of treating cancer with an antibody-drug conjugate |
| 07/09/2009 | US20090175887 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
| 07/09/2009 | US20090175883 Stabilized anti-respiratory syncytial virus (RSV) antibody formulations |
| 07/09/2009 | US20090175802 Tiotropium containing hfc solution formulations |
| 07/09/2009 | US20090175775 to coordinate vitamin B12 through its cyanide to a metal to form a [Co]-CN-M complex, wherein [Co] represents vitamin B12 without cyanide; such vitamin B12 derivatives are chemically stable and can be easily produced; e.g. use of precursor complex cis-diamminedichloroplatinum(II) |
| 07/09/2009 | CA2710835A1 Improved fibronectin-based binding molecules and their use |
| 07/09/2009 | CA2710713A1 Silencing of polo-like kinase expression using interfering rna |
| 07/09/2009 | CA2710379A1 Compositions containing sesamin-class compound(s) and quercetin glycoside(s) |
| 07/09/2009 | CA2710271A1 Enhancing photostabilization of oxymetazoline |
| 07/09/2009 | CA2709899A1 Pharmaceutical compositions containing at least one proteinaceous active ingredient protected against digestive enzymes |
| 07/09/2009 | CA2709781A1 Counter-pressure filtration of proteins |
| 07/09/2009 | CA2708627A1 High concentration antibody-containing liquid formulation |
| 07/09/2009 | CA2702478A1 Ophthalmic composition |
| 07/09/2009 | CA2701789A1 Novel taxoid-based compositions |
| 07/08/2009 | EP2077294A2 Dendritic polymers and magnetic resonance imaging contrast agent employing the same |
| 07/08/2009 | EP2077293A1 Block copolymer for drug complex and pharmaceutical composition |
| 07/08/2009 | EP2077121A1 Clotting factor VII-Fc chimeric proteins for treatment of a hemostatic disorder |
| 07/08/2009 | EP2077110A1 Glutamine-containing composition for increasing blood flow |
| 07/08/2009 | EP2077107A1 Calcium-containing structures and methods of making and using the same |
| 07/08/2009 | EP2077106A1 W/o/w emulsion composition |
| 07/08/2009 | EP2077105A1 Ophthalmic Micellar Compositions with Enhanced Stability |
| 07/08/2009 | EP2077104A1 Micellar compositions with ophtalmic applications |
| 07/08/2009 | EP2076557A1 Polylysine dendrimer contrast agent |
| 07/08/2009 | EP2076542A1 Use of monoclonal antibodies specific to the o-acetylated form of gd2 ganglioside for the treatment of certain cancers |
| 07/08/2009 | EP2076290A1 Multimeric tie 2 agonists and uses thereof in stimulating angiogenesis |
| 07/08/2009 | EP2076244A2 Aqueous systems for the preparation of lipid-based pharmaceutical compounds; compositions, methods, and uses thereof |
| 07/08/2009 | EP2076243A1 Liquid formulation of g-csf |
| 07/08/2009 | EP2076241A2 Fibrous calcium pyrophosphate particles and methods of making and using same |
| 07/08/2009 | EP1547170A4 Method for manufacture of films containing insoluble solids embedded in cellulose-based films |
| 07/08/2009 | EP1536768B1 Biodegradable composition with prolonged release of an antitumour agent and preparation thereof |
| 07/08/2009 | EP1511508A4 Method of treating dyslipidemic disorders |
| 07/08/2009 | EP1440962B1 Stabilized compositions of aqueous reduced coenzyme q solution |
| 07/08/2009 | EP1435918B1 Highly compressible ethylcellulose for tableting |
| 07/08/2009 | EP1432457B1 Sanitary napkins with hydrophobic lotions |
| 07/08/2009 | EP1412175B1 Insulating and functionalizing fine metal-containing particles with comformal ultra-thin films |
| 07/08/2009 | EP1171471B2 Enhanced gel strength methylcellulose |
| 07/08/2009 | EP1126826B9 Multiparticulate modified release composition of methylphenidate |
| 07/08/2009 | EP1009429B1 Compositions comprising the adjuvant qs-21 and polysorbate or cyclodextrin as excipient |
| 07/08/2009 | EP0669988B2 Angiogenesis inhibitory antibodies |
| 07/08/2009 | CN101474412A Preparation method of forsythoside-beta-cyclodextrin inclusion compound |
| 07/08/2009 | CN101474411A Anti-tumor prodrug using novel amphipathic hyperbranched polyesters as carrier and preparation method |
| 07/08/2009 | CN101474410A Heat-resisting lyophilized protecting agent of live vaccine for animal and preparation method thereof |
| 07/08/2009 | CN101474409A Inclusion method of medicament containing volatile component |
| 07/08/2009 | CN101474408A Polyethylene glycol monomethyl ether-polycaprolactone-polyphosphate triblock copolymer and siRNA medicament carrier prepared thereby |
| 07/08/2009 | CN101474407A Application of span 60 and/or span 80 in promoting absorption of coptis alkaloid |
| 07/08/2009 | CN101474406A Mono-layer oxidized mineral carbon and ferriferrous oxide composite material as well as preparation and application |
| 07/08/2009 | CN100510087C Modular transfection system |
| 07/08/2009 | CN100510068C A soluble complex comprising a retroviral surface glycoprotein |
| 07/08/2009 | CN100509842C Employment of rotavirus proteins, derived proteins and peptides for the modulation of tissue permeability |
| 07/08/2009 | CN100509061C 改进的螯合剂缀合物 Improved chelator conjugate |
| 07/08/2009 | CN100509060C Use of ethanol as plasticizer for preparing subcutaneous implants containing thermolabile active principles dispersed in a PLGA matrix |
| 07/08/2009 | CN100509059C Nanometer manetic powder for magnetothermical therapy and anti-CEA antibody target medicine |
| 07/08/2009 | CN100509058C Combinations of peroxisome proliferator-activated receptor (PPAR) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications |
| 07/08/2009 | CN100509057C Antigen arrays for treatment of bone disease |
| 07/08/2009 | CN100509056C Vaccines including as an adjuvant type 1 IFN and process related thereto |
| 07/08/2009 | CN100509054C Topical drug delivery using phosphatidylcholine |
| 07/08/2009 | CN100509053C Administration form for pharmaceutically active peptides with sustained release and method for the production thereof |
| 07/08/2009 | CN100509046C Beta-cyclodextrin and polyoxyethylenated castor oil for preparing injection liquid for restoring conscious ness and preparing method thereof |
| 07/08/2009 | CN100508990C Acrochordon alleviation |
| 07/08/2009 | CN100508988C Carbon dioxide external preparation and material for formation of carbon dioxide external preparation |
| 07/08/2009 | CN100508974C Transdermal patch for administering fentanyl |
| 07/08/2009 | CN100508965C Dosage forms having prolonged active ingredient release |
| 07/07/2009 | US7557183 Polyethylene glycol linked GLP-1 compounds |
| 07/07/2009 | US7557143 Such as 3,5-Dibromo-4-(4-hydroxy-3-phenethylcarbamoyl-phenoxy)-phenyl acetic acid; metabolism regulation agents; avoiding cardiovascular and other toxicities of hormones |
| 07/07/2009 | US7557094 Complex of chitosan, conjugated linoleic acid, vitamin a and cyclodextrin |
| 07/07/2009 | US7556863 Gold-coated nanoparticles for use in biotechnology applications |
| 07/07/2009 | US7556827 Implantable active ingredient depot comprising matrix of glyceryl-monooleate and at least one modifier molecule comprising 1,2-distearoyl-glycerophosphatidyl-ethanolamin-methyl-polyethylene glycol wherein matrix provides controlled release of active ingredient |
| 07/07/2009 | US7556821 Delivery system having a microprojection member that includes a plurality of microprojections adapted to pierce through stratum corneum into underlying epidermis layer; improved pharmacokinetics can comprise increased bioavailability of the PTH-based agent; treatment of osteoporosis and bone fractures |
| 07/07/2009 | US7556814 Antigen containing an attenuated strain of human immunodeficient virus; using psoralen and ultraviolet radiation |
| 07/07/2009 | US7556813 Antiviral peptide-polymer conjugate comprising a polymer covalently attached to two or more synthetic HIV gp41 HR1 and/or HR2 peptides |
| 07/07/2009 | US7556806 High mannose oligosaccharide cluster used to induce an immune response for increasing production of 2G12 antibodies |
| 07/07/2009 | US7556799 removing potassium from the gastrointestinal tract with a potassium-binding polymer; an alpha-fluoroacrylic acid polymer, or a difluoromaleic acid polymer crosslinked with vinylsulfonic acid, acrylic acid, vinyl phosphonate, vinyl-1,1-bisphosphonate, vinyl sulfonate, vinyl-1,2-disulfonate, itaconic aci |
| 07/07/2009 | CA2518195C Antitumor effect potentiator and antitumor agent |
| 07/07/2009 | CA2406790C Sustained release formulations |
| 07/07/2009 | CA2406119C Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets |
| 07/07/2009 | CA2400994C Radioactive therapeutic liposomes |
| 07/07/2009 | CA2388809C A topical, non-cytotoxic, antimicrobial hydrogel with thixotropic properties |
| 07/07/2009 | CA2380128C Plasters containing 4-biphenylacetic acid |